Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3,3-Dimethyl-1,5-dioxaspiro[5.5]undecan-9-ol → 2-(((4-((3,3-Dimethyl-1,5-dioxaspiro[5.5]undec-9-yl)oxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1h-benzimidazole sodium salt
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3,3-Dimethyl-1,5-dioxaspiro[5.5]undecan-9-ol | HCID 12470096 | — |
| 반응물 | 2-(((4-(((4r)-2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1h-benzimidazole sodium salt | HCID 66776552 | — |
| 생성물 | 2-(((4-((3,3-Dimethyl-1,5-dioxaspiro[5.5]undec-9-yl)oxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1h-benzimidazole sodium salt | HCID 66776456 | — |
반응 단계
The same procedure as in the steps (14a) to (14e) of Example 14 was repeated using the 3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-ol obtained in the step (81a) above to obtain the title compound (275 mg, the total yield of 5 steps: 3.3%) as a white solid. Note that in the same process as in the step (14b), after acetic anhydride was added, 10 equivalents of triethylamine relative to pyridine1-oxide derivative was added to perform the reaction. In the same process as in the step (14c), tetrahydrofuran was used as a solvent instead of ethanol.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07425634B2 |
| 출처 데이터셋 | uspto-grants-2008_09 |
| ORD ID | ord-515b25f2ec0c40cfa20553cc95a80cf8 |
| 출처 메모 | uspto-grants-2008_09 |